Trevia®R2

Therapeutic Segment:

Anti-Diabetic

Generic Name:

Ertugliflozin + Sitagliptin

Indication

Tablet
  • 5MG + 100MG
  • 15MG + 100MG

Trevia®R2 (Ertugliflozin + Sitagliptin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Ertugliflozin and Sitagliptin is appropriate.